Status:

COMPLETED

Lurasidone HCl A Phase 3 Study of Patients With Acute Schizophrenia

Lead Sponsor:

Sumitomo Pharma America, Inc.

Conditions:

Schizophrenia

Eligibility:

All Genders

18-75 years

Phase:

PHASE3

Brief Summary

Lurasidone HCl is a compound developed for the treatment of schizophrenia. This clinical study is designed to test the hypothesis that lurasidone is more efficacious than placebo. The study will also ...

Eligibility Criteria

Inclusion

  • Provide written informed consent and aged between 18 and 75 years of age.
  • Meets DSM-IV criteria for a primary diagnosis of schizophrenia.
  • Not pregnant, if of reproductive potential agrees to remain abstinent or use adequate and reliable contraception for duration of study.
  • Able and agrees to remain off prior antipsychotic medication for the duration of study.
  • Good physical health on the basis of medical history, physical examination, and laboratory screening.
  • Willing and able to comply with the protocol, including the inpatient requirements and outpatient visits.

Exclusion

  • Considered by the investigator to be at imminent risk of suicide or injury to self, others or property.
  • Any chronic organic disease of the CNS (other than schizophrenia).
  • Used investigational compound within 30 days.
  • Clinically significant or history of alcohol abuse/alcoholism or drug abuse/dependence within the last 6 months

Key Trial Info

Start Date :

January 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 1 2010

Estimated Enrollment :

478 Patients enrolled

Trial Details

Trial ID

NCT00615433

Start Date

January 1 2008

End Date

January 1 2010

Last Update

June 12 2015

Active Locations (52)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 13 (52 locations)

1

K&S Professional Research Services LLC

Little Rock, Arkansas, United States, 72201

2

Woodland International Research Group, LLC

Little Rock, Arkansas, United States, 72211

3

Clinical Pharmacological Studies, Inc.

Cerritos, California, United States, 90703

4

Excell Research

Oceanside, California, United States, 92056